135 related articles for article (PubMed ID: 35045559)
1. Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab.
Gordon RJ; Wells R; Johansen C; Liu S; Dahlberg SE; Snapper SB; Rufo PA
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):476-483. PubMed ID: 35045559
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens.
Pappa HM; Mitchell PD; Jiang H; Kassiff S; Filip-Dhima R; DiFabio D; Quinn N; Lawton RC; Bronzwaer ME; Koenen M; Gordon CM
J Clin Endocrinol Metab; 2014 Sep; 99(9):3408-17. PubMed ID: 24926949
[TBL] [Abstract][Full Text] [Related]
4. Single High-dose Vitamin D3 Supplementation in Pediatric Patients With Inflammatory Bowel Disease and Hypovitaminosis D.
Lee R; Maltz RM; Crandall WV; Plogsted SW; Shaikhkhalil AK; Bowden SA; Mezoff EA
J Pediatr Gastroenterol Nutr; 2020 Apr; 70(4):e77-e80. PubMed ID: 31860537
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels in IBD: a randomised trial of weight-based versus fixed dose vitamin D supplementation.
Kojecky V; Matous J; Kianicka B; Dite P; Zadorova Z; Kubovy J; Hlostova M; Uher M
Scand J Gastroenterol; 2020 Jun; 55(6):671-676. PubMed ID: 32538182
[No Abstract] [Full Text] [Related]
6. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens.
Pappa HM; Mitchell PD; Jiang H; Kassiff S; Filip-Dhima R; DiFabio D; Quinn N; Lawton RC; Varvaris M; Van Straaten S; Gordon CM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2134-42. PubMed ID: 22456619
[TBL] [Abstract][Full Text] [Related]
7. High-dose Cholecalciferol Supplementation in Adults with Cystic Fibrosis.
Janzen KM; Sakon C; Lehman A; Sommer B; Brown C
Pharmacotherapy; 2019 Sep; 39(9):874-880. PubMed ID: 31278763
[TBL] [Abstract][Full Text] [Related]
8. Single High-Dose Oral Vitamin D3 Therapy (Stoss): A Solution to Vitamin D Deficiency in Children With Inflammatory Bowel Disease?
Shepherd D; Day AS; Leach ST; Lopez R; Messenger R; Woodhead HJ; Ledder O; Lemberg DA
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):411-4. PubMed ID: 25883058
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial.
Talib HJ; Ponnapakkam T; Gensure R; Cohen HW; Coupey SM
J Pediatr; 2016 Mar; 170():266-72.e1. PubMed ID: 26707619
[TBL] [Abstract][Full Text] [Related]
10. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
Regalado Lam Chew Tun R; Porhownik N; Taback S; Oleschuk C
Clin Nutr ESPEN; 2018 Feb; 23():84-88. PubMed ID: 29460819
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency and its correction in children with sickle cell anaemia.
Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation in nursing home patients: randomized controlled trial of standard daily dose versus individualized loading dose regimen.
Wijnen H; Salemink D; Roovers L; Taekema D; de Boer H
Drugs Aging; 2015 May; 32(5):371-8. PubMed ID: 25899914
[TBL] [Abstract][Full Text] [Related]
13. Cholecalciferol loading dose guideline for vitamin D-deficient adults.
van Groningen L; Opdenoordt S; van Sorge A; Telting D; Giesen A; de Boer H
Eur J Endocrinol; 2010 Apr; 162(4):805-11. PubMed ID: 20139241
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.
Havens PL; Mulligan K; Hazra R; Flynn P; Rutledge B; Van Loan MD; Lujan-Zilbermann J; Kapogiannis BG; Wilson CM; Stephensen CB;
J Clin Endocrinol Metab; 2012 Nov; 97(11):4004-13. PubMed ID: 22933542
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study.
Fassio A; Adami G; Rossini M; Giollo A; Caimmi C; Bixio R; Viapiana O; Milleri S; Gatti M; Gatti D
Nutrients; 2020 May; 12(6):. PubMed ID: 32471106
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation dose needs to be higher in patients with inflammatory bowel disease: interventional study.
Kojecký V; Matouš J; Zádorová Z; Gřiva M; Kianička B; Uher M
Vnitr Lek; 2019; 65(7-8):470-474. PubMed ID: 31487989
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation.
Papaioannou A; Kennedy CC; Giangregorio L; Ioannidis G; Pritchard J; Hanley DA; Farrauto L; DeBeer J; Adachi JD
BMC Musculoskelet Disord; 2011 Jun; 12():135. PubMed ID: 21689448
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D supplementation for sickle cell disease.
Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
[TBL] [Abstract][Full Text] [Related]
19. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease.
Simek RZ; Prince J; Syed S; Sauer CG; Martineau B; Hofmekler T; Freeman AJ; Kumar A; McElhanon BO; Schoen BT; Tenjarla G; McCracken C; Ziegler TR; Tangpricha V; Kugathasan S
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):252-8. PubMed ID: 26196201
[TBL] [Abstract][Full Text] [Related]
20. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
Trials; 2014 Nov; 15():430. PubMed ID: 25376735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
